News

Elieen, Actual Sientra Patient

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) December 10, 2018
Sientra Reports Third Quarter 2018 Financial Results November 6, 2018
Sientra to Participate in Upcoming Investor Conferences October 31, 2018
Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018 October 23, 2018
Sientra Announces FULL CIRCLE Grant Recipients October 23, 2018
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 17, 2018
Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations August 15, 2018
Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 10, 2018
Sientra Reports Second Quarter 2018 Financial Results August 7, 2018
Sientra to Launch State-of-the-Art Innovation Facility July 31, 2018
Sientra to Present at the Canaccord 38th Annual Growth Stock Conference July 25, 2018
Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018 July 24, 2018
Sientra to Present at the William Blair 38th Annual Growth Stock Conference June 4, 2018
Sientra Reports First Quarter 2018 Financial Results May 9, 2018
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option May 7, 2018
Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018 May 4, 2018
Sientra Announces Pricing of Upsized Public Offering of Common Stock May 3, 2018
Sientra Commences Public Offering of Common Stock April 30, 2018
Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting April 25, 2018
Sientra Receives FDA Approval of PMA Supplement April 18, 2018
Sientra Reports Fourth Quarter and Full Year 2017 Financial Results March 13, 2018
Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2018 March 2, 2018
Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting February 16, 2018
Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility January 30, 2018
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) January 25, 2018
Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue January 8, 2018

Nasdaq: SIEN

Stock Quote: NASD

$1.58 -0.09
Volume 200,163
Previous Close 1.67
Intraday High 1.67
Intraday Low 1.39
Pricing delayed 20 minutes
Price Change % Change -5.61% 52 Week High 23.05 52 Week Low 1.28 Today's Open 1.60 Mar 31, 2023 03:57 PM

Email Alerts

Email: *
Subscription Preferences *




 
Enter the code shown above.

Investor Contact

Sientra Investor Relations
ir@sientra.com

© 2021 Sientra, Inc. All rights reserved.